Other news
Other news
IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.
Read full storyOther news
Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets
Read full storyOther news
Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials
Read full storyOther news
Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis
Read full storyOther news
Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies
Read full storyOther news
Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates
Read full storyOther news
JLABS TMC Company finds Growth in Shrinking Cells
Read full storyOther news
With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline
Read full storyOther news
Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline
Read full storyOther news
Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease
Read full storyOther news
Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614
Read full storyOther news
Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm for Drug Development
Read full storyOther news
Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder
Read full storyOther news